Bill · S. 3188· Senate(119-S-3188)
Biomanufacturing Excellence Act of 2025
- Introduced
- 11/18/2025
- Last activity
- 11/18/2025 — Read twice and referred to the Committee on Commerce, Science, and Transportation.
- Sponsored by
- Christopher Coons
- Cosponsors
- - 2 - 3
- Introduced
- In Committee
What this bill would do
The Biomanufacturing Excellence Act of 2025 aims to establish a National Biopharmaceutical Manufacturing Center of Excellence. This center is intended to advance the science of biopharmaceutical manufacturing to protect national, health, and economic security. The bill directs the Director to award grants or agreements to eligible entities, such as higher education institutions or public-private partnerships, to operate the center. Objectives include improving manufacturing technologies, supporting workforce training, and developing necessary infrastructure. The center will also focus on reducing supply chain bottlenecks and strengthening self-sufficiency. This legislation authorizes $120,000,000 for fiscal year 2026 to carry out these efforts.
Yes· 3 of 12
Does this put more money into scientific research?+7
The bill authorizes $120,000,000 to fund collaborative research and development in biomanufacturing.
Is this likely to create jobs?+5
The bill promotes workforce training and development to bolster talent in the biotechnology sector.
Would business owners be better off under this?+5
The bill provides resources to help manufacturers scale their products and achieve a return on investment.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved Health and Treatments: The bill notes that biopharmaceutical manufacturing can enable better and less invasive treatments that extend and improve lives (Section 2(a)(3)).
-
Workforce Training and Development: The center is tasked with advancing workforce training and working with educational and community partners to bolster biotechnology talent (Section 3(a)(2)(C)). Funding can specifically be used for these workforce training programs (Section 3(a)(3)(C)).
-
Increased Supply Chain Security: By investing in biomanufacturing, the government aims to reduce dependency on foreign supply chains (Section 2(a)(4)). The center's objectives include reducing supply bottlenecks and strengthening supply chain self-sufficiency (Section 3(a)(2)(A)(i)).
-
Economic and National Security: The center aims to advance science related to products of particular importance to the national security, health security, or economic security of the United States (Section 3(a)(2)(A)).
Potential Negative Impacts for People
- No specific negative impacts or burdens are explicitly stated in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Economy And Finance
- Increases Job Creation+5Improves Economic Growth+4Improves Small Business Support+3
- Demographic And Interest Groups
- Good For Business Owners+5Good For Students+4
- Education And Technology
- Increases Scientific Research Funding+7Improves College Affordability+2
- Healthcare
- Improves Healthcare Access+4
- Governance And Ideology
- Improves Government Transparency+3
- Environment Energy And Infrastructure
- Improves Rural Development+1
- National Security And Foreign Policy
- Improves Cybersecurity Defense+1
- Social Issues And Justice
- Improves Poverty Reduction+1
- 5/19/2026
- 1 Cosponsor added.
- 5/14/2026
- 1 Cosponsor added.
- 3/11/2026
- 2 Cosponsors added.
- 11/18/2025
- Read twice and referred to the Committee on Commerce, Science, and Transportation.
- 1 Cosponsor added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Lisa Blunt RochesterDemocrat · Delaware
Ted BuddRepublican · North Carolina
Alex PadillaDemocrat · California
Thomas TillisRepublican · North Carolina
Todd YoungRepublican · Indiana